Time and Venue
| Date | March 4, 2024 (Mon) 13:00-16:10 |
|---|---|
| Venue | Online (Zoom) |
| 13:00-13:05 | Opening Remarks Masato Maruyama, Okayama University |
| 13:05-14:05 |
Research Presentation (15 min talk + 5 min discussion) Chair: Takaya Matsuda, Astellas Pharma Inc. RP-01. Kidney-targeted delivery of medium-sized peptide, using L-serine-modified macromolecular drug carrier for the treatment of kidney diseases 〇Miki Imanishi, Hidemasa Katsumi, Masaki Morishita, Akira Yamamoto Department of Biopharmaceutics, Kyoto Pharmaceutical University |
| RP-02. Establishment of cancer stem-like cell lines from mouse breast cancer 4T1 cells 〇Taketo Yoshitomi, Miho Seguchi, Masato Maruyama, Kazutaka Higaki Department of Pharmaceutics, Graduate School of Medicine, Dentistry and Pharmaceutical Science, Okayama University. |
|
| RP-03. Programmed cell-immobilization of living cells by interaction of independent pairs 〇Zhu Chengyuan Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University |
|
| 14:05-14:20 | Break |
| 14:20-16:05 | Invited Lecture (25 min talk + 10 min discussion) Chair: Masato Maruyama, Okayama University IL-01. The extent of enzymatic hydrolysis of acyl glucuronides in liver microsomes can be one of the determinants of idiosyncratic drug toxicity risk 〇Hiroaki Shimada Department of Pharmacy, Faculty of Pharmacy, Kindai University |
| IL-02. Contribution of Biopharmaceutics Research to Oral Formulation Development in Pharmaceutical Industry 〇Tsuyoshi Kiyota, 〇Yuki Ando Pharmaceutical Research and Technology Labs., Astellas Pharma Inc. |
|
| IL-03. Microphysiological Systems: Advancements and Applications in Pharmaceutical Research 〇Abdalkader Rodi Ritsumeikan Global Innovation Research Organization, Ritsumeikan University |
|
| 16:05-16:10 | Closing Remarks Takaya Matsuda, Astellas Pharma Inc. |